Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01NAM
|
||||
Former ID |
DCL001108
|
||||
Drug Name |
ELB-139
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Anxiety disorder [ICD9: 300, 311; ICD10:F32, F40-F42] | Discontinued in Phase 2 | [547900] | ||
Therapeutic Class |
Psychiatric
|
||||
Company |
Elbion AG; 4AZA Bioscience
|
||||
Structure |
Download2D MOL |
||||
Formula |
C14H16ClN3O
|
||||
Canonical SMILES |
C1CCN(CC1)C2C=NC(=O)N2C3=CC=C(C=C3)Cl
|
||||
InChI |
1S/C14H16ClN3O/c15-11-4-6-12(7-5-11)18-13(10-16-14(18)19)17-8-2-1-3-9-17/h4-7,10,13H,1-3,8-9H2
|
||||
InChIKey |
QVAPXAJYAPCWAI-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Glutamate receptor AMPA subtype | Target Info | Modulator | [536166] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.